ATPGQ yields 1000000.00% · JNJ yields 2.13%● Live data
📍 ATPGQ pulled ahead of the other in Year 1
Combined, ATPGQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATPGQ + JNJ for your $10,000?
On October 12, 2021, ATP Oil & Gas Corp. went out of business as per its Chapter 7 liquidation filing under bankruptcy. ATP Oil & Gas Corp. engages in the acquisition, development, and production of oil and natural gas properties primarily in the Gulf of Mexico and the United Kingdom sector of the North Sea. The company also has interests in three deepwater licenses in the Mediterranean Sea off the coast of Israel. As of December 31, 2011, it had estimated net proved reserves of 118.9 million barrels of crude oil equivalent (MMBoe), of which approximately 75.9 MMBoe were in the Gulf of Mexico and 42.9 MMBoe were in the North Sea. The company's reserves comprised approximately 78.6 million barrels of crude oil or other liquid hydrocarbons and 241.5 billion cubic feet of natural gas. It also owned leasehold and other interests in 38 offshore blocks and 49 wells comprising 23 subsea wells in the Gulf of Mexico, as well as had interests in 13 blocks and 2 company-operated subsea wells in the North Sea. ATP Oil & Gas Corporation was founded in 1991 and is headquartered in Houston, Texas.
Full ATPGQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.